Cargando…
Immunomodulatory mechanisms of abatacept: A therapeutic strategy for COVID-19
Coronavirus disease 2019 (COVID-19) caused by coronavirus-2 (SARS-CoV-2) infection has rapidly spread throughout the world and become a major threat to human beings. Cytokine storm is a major cause of death in severe patients. Abatacept can suppress cytokines used as antirheumatic drugs in clinical...
Autores principales: | Yang, Dinglong, Li, Hetong, Chen, Yujing, Ren, Weiping, Dong, Mingjie, Li, Chunjiang, Jiao, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357915/ https://www.ncbi.nlm.nih.gov/pubmed/35957855 http://dx.doi.org/10.3389/fmed.2022.951115 |
Ejemplares similares
-
A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
por: Yang, Dinglong, et al.
Publicado: (2022) -
BCL7B is a potential novel diagnosis and prognosis biomarker for sarcomas using bioinformatics analysis
por: Yang, Dinglong, et al.
Publicado: (2021) -
Comparison of posterior cruciate retention and substitution in total knee arthroplasty during gait: a systematic review and meta-analysis
por: Li, Chunjiang, et al.
Publicado: (2022) -
Immunomodulatory therapies for COVID-19
por: Mathur, Poonam, et al.
Publicado: (2022) -
Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy
por: Li, Hetong, et al.
Publicado: (2022)